Viable SARS-CoV-2 Omicron sub-variants isolated from autopsy tissues

• DOI: 10.3389/fmicb.2023.1192832
• Publication Date: 2023-05-22T04:55:25Z
• Authors: Santiago Maffia-B...; Cintia Cevallos; Federico Remes Le...; Rosa Nicole Freib...; Cinthya Alicia Ma...; Alex Guano Toaquiza; Franco Sviercz; Patricio Jarmoluk; Cristina Bustos; Adriana Claudia D...; Jorge Quarleri; M. Victoria Delpino
• Keywords: Vero E6 cell line; SARS-COV-2; Infectious disease (medical specialty); Coronavirus Disease 2019 Research; FOS: Health sciences; Diagnostic Methods for COVID-19 Detection; POSTMORTEM TISSUE; Microbiology; Tropism; Gene; Coronavirus Disease 2019; https://purl.org/becyt/ford/3.3; Virology; Health Sciences; Viral replication; Pathology; Genetics; Viral load; Disease; https://purl.org/becyt/ford/3; Biology; virus isolation; SARS-CoV-2; Vero cell; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); postmortem tissue; COVID-19; OMICRON VARIANTS; VIRUS ISOLATION; VERO E6 CELL LINE; QR1-502; 3. Good health; Virus; Coronavirus; Coronavirus disease 2019 (COVID-19); Infectious Diseases; Tissue tropism; Infectivity; omicron variants; FOS: Biological sciences; Viral Transmission; Medicine; RNA; Autopsy

IntroductionPulmonary and extrapulmonary manifestations have been described after infection with SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19). The virus is known to persist in multiple organs due to its tropism for several tissues. However, previous reports were unable to provide definitive information about whether the virus is viable and transmissible. It has been hypothesized that the persisting reservoirs of SARS-CoV-2 in tissues could be one of the multiple potentially overlapping causes of long COVID.MethodsIn the present study, we investigated autopsy materials obtained from 21 cadaveric donors with documented first infection or reinfection at the time of death. The cases studied included recipients of different formulations of COVID-19 vaccines. The aim was to find the presence of SARS-CoV-2 in the lungs, heart, liver, kidneys, and intestines. We used two technical approaches: the detection and quantification of viral genomic RNA using RT-qPCR, and virus infectivity using permissivein vitroVero E6 culture.ResultsAll tissues analyzed showed the presence of SARS-CoV-2 genomic RNA but at dissimilar levels ranging from 1.01 × 102copies/mL to 1.14 × 108copies/mL, even among those cases who had been COVID-19 vaccinated. Importantly, different amounts of replication-competent virus were detected in the culture media from the studied tissues. The highest viral load were measured in the lung (≈1.4 × 106copies/mL) and heart (≈1.9 × 106copies/mL) samples. Additionally, based on partial Spike gene sequences, SARS-CoV-2 characterization revealed the presence of multiple Omicron sub-variants exhibiting a high level of nucleotide and amino acid identity among them.DiscussionThese findings highlight that SARS-CoV-2 can spread to multiple tissue locations such as the lungs, heart, liver, kidneys, and intestines, both after primary infection and after reinfections with the Omicron variant, contributing to extending knowledge about the pathogenesis of acute infection and understanding the sequelae of clinical manifestations that are observed during post-acute COVID-19.